Acquisition of chemical compounds for ncats pre-clinical library - antiviral initiative

Ended Purchase Order Awarded Last action

Contract number
75N95021P00688
Awardee
Awarding agency
Obligated
$391,467

Award facts

Opportunity
Contract value 100% obligated
$391,467.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
PSC
6810 Chemicals
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Jose, CA 95123, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $391,467

About this award

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $391,467 firm fixed price purchase order to Pointcare Systems Inc. R&D Division, doing business as Chirosolve, to acquire 97 specified chemical compounds for NCATS' pre-clinical library in support of its antiviral initiative. The solicitation sought quotes for delivery of the chemical compounds to locations in the United States by September 2022, with award made to Chirosolve as a total small business set-aside. No major subcontractors were identified. This contract will provide research-enabling compounds to NCATS, which works to reduce the time and cost of developing new medicines and get more treatments to more patients more quickly through a variety of pre-clinical and clinical research programs and resources.

Quick answers

Who was awarded contract 75N95021P00688?

75N95021P00688 was awarded to Pointcare Systems Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 23, 2021.

How much is contract 75N95021P00688 worth?

The government has obligated $391,467 on 75N95021P00688.

Which agency awarded contract 75N95021P00688?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00688, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95021P00688 competed?

The extent of competition for 75N95021P00688 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award